SCHEMBL20381752

SCHEMBL20381752

C=C1Cc2ccccc2C(=C2CCN(Cc3ncccc3C)CC2)c2ccsc21

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HRH1 P35367 14/20 0.48
▸ DRD3 P35462 5/20 0.48
▸ CHRM2 P08172 4/20 0.48
▸ CHRM1 P11229 4/20 0.48
▸ HTR2A P28223 4/20 0.48
▸ HTR2C P28335 4/20 0.48
▸ LMNA P02545 3/20 0.48
▸ ADRA2A P08913 3/20 0.48
▸ ADRA2B P18089 3/20 0.48
▸ DRD1 P21728 3/20 0.48
▸ HTR3A P46098 3/20 0.48
▸ ADRA1A P35348 3/20 0.48
▸ OPRK1 P41145 3/20 0.48
▸ HTR2B P41595 3/20 0.48
▸ KCNH2 Q12809 3/20 0.48
▸ CHRM4 P08173 2/20 0.48
▸ CHRM5 P08912 2/20 0.48
▸ CHRM3 P20309 2/20 0.48
▸ HTR6 P50406 2/20 0.48
▸ ADRA2C P18825 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14474309 0.89 HRH1 (0.63) HRH1DRD3CHRM2CHRM1HTR2A
SCHEMBL20978932 0.88 HRH1 (0.50) HRH1DRD3CHRM2CHRM1HTR2A
SCHEMBL14475369 0.83 HRH1 (0.49) HRH1DRD3CHRM2CHRM1HTR2A
SCHEMBL14473930 0.83 HRH1 (0.47) HRH1DRD3CHRM2CHRM1HTR2A
SCHEMBL14475366 0.81 HRH1 (0.48) HRH1DRD3CHRM2CHRM1HTR2A
SCHEMBL14474697 0.80 DRD3 (0.48) HRH1DRD3CHRM2CHRM1HTR2A
SCHEMBL20978905 0.79 HRH1 (0.54) HRH1DRD3CHRM2CHRM1HTR2A
SCHEMBL14475371 0.77 HRH1 (0.64) HRH1DRD3CHRM2CHRM1HTR2A
SCHEMBL14474308 0.72 HRH1 (0.63) HRH1DRD3CHRM2CHRM1HTR2A
SCHEMBL14475370 0.72 DRD3 (0.63) HRH1DRD3CHRM2CHRM1HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10022362-B2 Anti-allergy benzocycloheptathiophene derivatives FUJIAN MINDONG REJUVENATION PHARMACEUTICAL CO., LTD (CN) 2018-07-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10022362-B2 Anti-allergy benzocycloheptathiophene derivatives NR1H4, TST, CYP7A1 HRH1 14/4885DRD3 2282/4885CHRM2 3007/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback